By Tyler Micik
The Delaware Manufacturing Association (DMA) recently met to discuss SB 1, the Healthy Delaware Families Act; HB 305, legalization of recreational marijuana; and HB 288, paid time off to vote.
Manufacturers like many others are facing significant labor shortages despite offering competitive wages, sign-on bonuses, good benefits packages, and more. The board met to talk about these proposals and share their feedback on the potential impact these bills, if passed, would have on the manufacturing industry--which employs more than 27,000 Delawareans.
Other topics discussed included President Biden’s vaccine mandate, which was blocked by the U.S. Supreme Court. The mandate would have required companies with 100 or more employees to get vaccinated or produce a negative test result on a weekly basis staring January 4th.
Lastly, the board discussed the State Chamber’s Spring Manufacturing and Policy Conference. The conference will be held virtually on March 16th from 8:30 – 11:30am. The event will feature Dr. Kelvin Lee, institute director at the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL). Dr. Lee will share how NIIMBL is working to ensure the U.S. cements its leadership in global biomanufacturing to further economic development, enhance national security, and provide improved patient access to cutting-edge therapies—today and in the future. The conference will also feature a keynote address from Governor John Carney and a discussion on the State Chamber's policy priorities to improve Delaware's economic climate and encourage manufacturers to both relocate and grow in our state. You can register for the event here.